Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Markets and distributes specialty, artisanal and farmstead cheese products

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

Guangdong Tiankeya Biomedical Technology Co., Ltd., established on 2019-01-10, Business scope includes research and development of biological products(Does not include licensed operations);Medical technology research and development;Health Sciences Program Research,to develop;Human Science Research,to develop;Natural science research and experimental development;Stem Cell Technology Research,to develop;Biomedical Technology Research;Pharmaceutical Research Services;Stem Cell Drug Development;Medical Research and Experimental Development;Operation of non-licensed medical devices;Research and development of biodiagnostic reagents and kits(Does not include license approval items);Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Biological Products Testing;Import and export(Excluding franchised products);Technology Import and Export;Technology development of stem cell engineering series products;Research and development of stem cell series technical engineering products;Stem Cell Biotechnology Consulting Services;Stem Cell Biotechnology Transfer Services;Stem Cell Biotechnology Services;Licensed medical device business;Manufacture of stem cell series technical engineering products;Preparation of cell preparations and related products;Manufacture of stem cell engineering series products;Sales of stem cell engineering series products;Sales of stem cell series technical engineering products;Sales of cell preparations and related products;collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage)

Verthermia Acquisition, Inc. provides healthcare services. The company is headquartered in Reno, NV.

FIT Biotech Oy engages in the research, development and manufacture of diagnostic laboratory tests and pharmaceutical products. It develops and markets Gene Transport Unit vector technology to be used as a gene transport mechanism in gene therapeutic applications. The company was founded on May 17, 1995 and is headquartered in Tampere, Finland.

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Estabished in1950, Snow Brand Milk Products Co. Ltd. is a Japanese dairy company that manufactures cheese, butter, milk and other dairy products. They also manufacture fruit juices and frozen desserts and offers home milk delivery service. Snow Brand has several offices and factories around Japan.

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.